The mutating SARS-CoV-2 is gaining virulence against the young COVID-19 patients | Demiurge Technologies

“As the world’s first AI-biopharma company that has discovered and publicized the precise aetiology and pathology of COVID-19, we are committed to the non-profit dissemination of our COVID-19 discoveries and the public validation of our COVID-19 clinical predictions.”

Read the full article @ Demiurge Technologies:

634 thoughts on “The mutating SARS-CoV-2 is gaining virulence against the young COVID-19 patients | Demiurge Technologies”